IntraBio Inc.: IntraBio Completes Recruitment for IB1001 NPC Pivotal Clinical Trial
IntraBio's pivotal trial for Niemann-Pick disease type C has completed recruitmentIntraBio's pivotal trial data readout expected Q2 2023OXFORD, UK / ACCESSWIRE / December 8, 2022 / IntraBio Inc announced
United States United Kingdom Kostenloser Wertpapierhandel Development Program Approvalpathway University Of Oxford Product Development Officer
Source: finanznachrichten.de